Cheryl A. Janson

7.4k total citations · 1 hit paper
67 papers, 5.1k citations indexed

About

Cheryl A. Janson is a scholar working on Molecular Biology, Materials Chemistry and Oncology. According to data from OpenAlex, Cheryl A. Janson has authored 67 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 21 papers in Materials Chemistry and 13 papers in Oncology. Recurrent topics in Cheryl A. Janson's work include Enzyme Structure and Function (20 papers), Biochemical and Molecular Research (16 papers) and RNA and protein synthesis mechanisms (8 papers). Cheryl A. Janson is often cited by papers focused on Enzyme Structure and Function (20 papers), Biochemical and Molecular Research (16 papers) and RNA and protein synthesis mechanisms (8 papers). Cheryl A. Janson collaborates with scholars based in United States, United Kingdom and Switzerland. Cheryl A. Janson's co-authors include Ward W. Smith, Xiayang Qiu, Robert J. Almassy, David Eisenberg, Sherin S. Abdel‐Meguid, David A. Matthews, David Payne, John T. Lonsdale, Duilio Cascio and W. W. Cleland and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Cheryl A. Janson

67 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development

2013 447 citations Cheryl A. Janson et al. Journal of Medicinal Chemistry profile →

Peers

Countries citing papers authored by Cheryl A. Janson

Since Specialization

Citations

This map shows the geographic impact of Cheryl A. Janson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl A. Janson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl A. Janson more than expected).

Fields of papers citing papers by Cheryl A. Janson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl A. Janson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl A. Janson. The network helps show where Cheryl A. Janson may publish in the future.

Co-authorship network of co-authors of Cheryl A. Janson

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl A. Janson. A scholar is included among the top collaborators of Cheryl A. Janson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl A. Janson. Cheryl A. Janson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Crystal structure of dihydrofolate reductase from the filarial nematode W. bancrofti in complex with NADPH and folate 2023 ·PLoS neglected tropical diseases ·(unknown), Kathleen M. Frey, (unknown), Cheryl A. Janson, Ueli Gubler, Nina M. Goodey	1
2	Investigating the Roles of Active Site Residues in Mycobacterium tuberculosis Indole-3-glycerol Phosphate Synthase, a Potential Target for Antitubercular Agents 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Joseph Lacap, (unknown), (unknown), (unknown), (unknown), Cheryl A. Janson, (unknown), Nina M. Goodey	1
3	Expression, purification, and inhibition profile of dihydrofolate reductase from the filarial nematode Wuchereria bancrofti 2018 ·PLoS ONE ·Andrew M. Tobias, (unknown), (unknown), (unknown), (unknown), Cheryl A. Janson, David P. Rotella, Ueli Gubler, Nina M. Goodey	9
4	Crystal Structures of IL‐2‐inducible T cell Kinase Complexed with Inhibitors: Insights into Rational Drug Design and Activity Regulation 2010 ·Chemical Biology & Drug Design ·Alan K. Kutach, Armando G. Villaseñor, (unknown), Charles Belunis, Cheryl A. Janson, (unknown), (unknown), (unknown), Jérôme Deval, Thomas J. Novak, Jim Barnett, (unknown), David E. Shaw, A. Kuglstatter	33
5	Structure of apo acyl carrier protein and a proposal to engineer protein crystallization through metal ions 2004 ·Acta Crystallographica Section D Biological Crystallography ·Xiayang Qiu, Cheryl A. Janson	36
6	Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase 2002 ·Acta Crystallographica Section D Biological Crystallography ·P.A. Elkins, (unknown), Ward W. Smith, Cheryl A. Janson, Karla D'Alessio, Michael S. McQueney, Maxwell D. Cummings, Anne M. Romanic	124
7	Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors 2001 ·Protein Science ·Xiayang Qiu, Cheryl A. Janson, Ward W. Smith, Susan M. Green, Patrick McDevitt, Kyung Johanson, Paul Carter, Martin Hibbs, Ceri Lewis, Alison F. Chalker, Andrew Fosberry, Judith M. LaLonde, John M. Berge, Pamela Brown, C. S. V. HOUGE‐FRYDRYCH, Richard L. Jarvest	166
8	1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI) 2001 ·Bioorganic & Medicinal Chemistry Letters ·Dirk A. Heerding, George Chan, Walter E. DeWolf, Andrew Fosberry, Cheryl A. Janson, Deborah D. Jaworski, Edward C. McManus, William H. Miller, Terrance Moore, David Payne, Xiayang Qiu, Stephen Rittenhouse, (unknown), Ward W. Smith, Dennis T. Takata, (unknown), Catherine Yuan, William F. Huffman	110
9	Structure-based combinatorial library design: Discovery of non-peptidic inhibitors of caspases 3 and 8 2001 ·Journal of Computer-Aided Molecular Design ·Martha S. Head, Margret Ryan, Dennis Lee, (unknown), Cheryl A. Janson, N.O. Concha, Paul M. Keller, Walter E. DeWolf	3
10	Crystallization ofEscherichia coliβ-ketoacyl-ACP synthase III and the use of a dry flash-cooling technique for data collection 2000 ·Acta Crystallographica Section D Biological Crystallography ·Cheryl A. Janson, Alex K. Konstantinidis, John T. Lonsdale, Xiayang Qiu	3
11	Crystal Structure of β-Ketoacyl-Acyl Carrier Protein Synthase III 1999 ·Journal of Biological Chemistry ·Xiayang Qiu, Cheryl A. Janson, Alex K. Konstantinidis, (unknown), Carol Silverman, Ward W. Smith, Sanjay Khandekar, John T. Lonsdale, Sherin S. Abdel‐Meguid	130
12	Unique fold and active site in cytomegalovirus protease 1996 ·Nature ·Xiayang Qiu, Jeffrey S. Culp, Anthony G. DiLella, Brian D. Hellmig, Susan S. Hoog, Cheryl A. Janson, Ward W. Smith, Sherin S. Abdel‐Meguid	118
13	Structure of and kinetic channelling in bifunctional dihydrofolate reductase–thymidylate synthase 1994 ·Nature Structural Biology ·Daniel R. Knighton, Chen‐Chen Kan, Eleanor F. Howland, Cheryl A. Janson, Zuzana Hostomska, Katherine M. Welsh, David A. Matthews	169
14	Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein 1994 ·Cell ·David A. Matthews, Ward W. Smith, Rose Ann Ferre, (unknown), (unknown), (unknown), J. Ernest Villafranca, Cheryl A. Janson, (unknown), (unknown), Stephen T. Worland	285
15	Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones 1993 ·Journal of Medicinal Chemistry ·Stephen E. Webber, (unknown), (unknown), Judith G. Deal, (unknown), (unknown), Stephanie Webber, Cheryl A. Janson, David Matthews	128
16	Heterologous expression and purification of active human phosphoribosylglycinamide formyltransferase as a single domain 1992 ·Journal of Protein Chemistry ·Chen‐Chen Kan, Michael R. Gehring, B R Nodes, Cheryl A. Janson, Robert J. Almassy, Zuzana Hostomska	20
17	Design and synthesis of novel 6,7-imidazotetrahydroquinoline inhibitors of thymidylate synthase using iterative protein crystal structure analysis 1992 ·Journal of Medicinal Chemistry ·Siegfried Reich, Mary Ann M. Fuhry, (unknown), (unknown), Katherine M. Welsh, Stephanie Webber, Cheryl A. Janson, Steven R. Jordan, David A. Matthews	45
18	Stereochemical mechanism of action for thymidylate synthase based on the X-ray structure of the covalent inhibitory ternary complex with 5-fluoro-2′-deoxyuridylate and 5,10-methylenetetrahydrofolate 1990 ·Journal of Molecular Biology ·David A. Matthews, J. Ernest Villafranca, Cheryl A. Janson, Ward W. Smith, Katherine M. Welsh, (unknown)	99
19	Refined atomic model of glutamine synthetase at 3.5 A resolution. 1989 ·PubMed ·M M Yamashita, Robert J. Almassy, Cheryl A. Janson, Duilio Cascio, David Eisenberg	127
20	Some Evolutionary Relationships of the Primary Biological Catalysts Glutamine Synthetase and RuBisCO 1987 ·Cold Spring Harbor Symposia on Quantitative Biology ·David Eisenberg, Robert J. Almassy, Cheryl A. Janson, Michael S. Chapman, Se Won Suh, Duilio Cascio, (unknown)	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact